MedPath

Astellas Pharma Taiwan, Inc.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

Phase 4
Completed
Conditions
Lower Urinary Tract Symptoms
Overactive Bladder
Benign Prostatic Hyperplasia (BPH)
Interventions
First Posted Date
2016-03-22
Last Posted Date
2016-03-22
Lead Sponsor
Astellas Pharma Taiwan, Inc.
Target Recruit Count
52
Registration Number
NCT02715024
Locations
🇨🇳

Site, Taipei, Taiwan

A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout

Phase 3
Completed
Conditions
Gout
Interventions
First Posted Date
2012-11-29
Last Posted Date
2014-10-29
Lead Sponsor
Astellas Pharma Taiwan, Inc.
Target Recruit Count
109
Registration Number
NCT01736514
© Copyright 2025. All Rights Reserved by MedPath